GTCR looks to replicate Resonetics' success with new investment Biocoat

GTCR managing director Luke Marker discusses the Chicago PE firm's recent investment in the maker of coatings for medical devices.

17 November 2022•5 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles